Company Filing History:
Years Active: 2025
Title: The Innovations of Peter Bowers
Introduction
Peter Bowers is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of immunology, particularly through his innovative work on antibodies. His research focuses on the interleukin 36 receptor (IL-36R), which plays a crucial role in various diseases.
Latest Patents
Bowers holds a patent for "Antibodies directed against interleukin 36 receptor (IL-36R)." This invention relates to isolated immunoglobulin heavy chain and light chain polypeptides that bind to the IL-36R protein. The patent provides an IL-36R-binding agent that includes these immunoglobulin polypeptides. Additionally, it encompasses related vectors, compositions, and methods for using the IL-36R-binding agent to treat disorders responsive to IL-36R inhibition, such as cancer, infectious diseases, and autoimmune diseases.
Career Highlights
Peter Bowers is currently associated with Anaptysbio, Inc., where he continues to advance his research in immunology. His work has the potential to impact the treatment of various diseases significantly. Bowers' dedication to innovation in this field is evident through his patent and ongoing research efforts.
Collaborations
Bowers collaborates with notable colleagues, including Andrew John McKnight and David J King. Their combined expertise contributes to the advancement of research in immunology and the development of new therapeutic approaches.
Conclusion
Peter Bowers is a prominent inventor whose work on IL-36R-binding agents holds promise for treating serious health conditions. His contributions to immunology exemplify the impact of innovative research in medicine.